Trial Profile
A phase III trial to investigate the efficacy of human central nervous system stem cells (HuCNS-SC) in patients with chronic spinal cord injury
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 24 Dec 2015
Price :
$35
*
At a glance
- Drugs Adult neural stem cells (Primary)
- Indications Spinal cord injuries
- Focus Therapeutic Use
- Sponsors StemCells
- 24 Dec 2015 New trial record